Indeed, MYC-independent ESRP1 amplification in early onset prostate cancer correlates with more advanced cancer histology and high mitotic activity of tumour cells, and is also predictive of a shorter time to disease recurrence [14]. This evidence concerns the gene ESRP1 and prostate carcinoma.